Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Ming Peng

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
BMJ Open|July 9, 2018
Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countriesHsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, et al.
World Journal of Gastrointestinal Surgery|January 2, 2026
Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIIICheng-Ming Peng, Shao-Chieh Lin, Yung-Yin Cheng, et al.
Cancer Medicine|February 24, 2023
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapyCho-Han Chiang, Yu-Cheng Chang, Shih-Syuan Wang, et al.
Surgical Endoscopy|July 24, 2024
Reduced-port robotic pancreaticoduodenectomy with optimized surgical field deployment: early results of single-site plus-two ports methodRiki Ninomiya, Masahiko Komagome, Satoru Abe, et al.
Oncology|May 28, 2023
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint InhibitorsCho-Han Chiang, Yuan-Jen Chen, Xin Ya See, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2023
Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort studyCho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, et al.
Japanese Journal of Clinical Oncology|October 8, 2022
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populationsCho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, et al.
American Journal of Cancer Research|December 12, 2022
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinomaNai-Jung Chiang, Yan-Shen Shan, Chung-Pin Li, et al.
Journal of Gastroenterology and Hepatology|January 31, 2024
The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancerCho-Han Chiang, Cho-Hung Chiang, Yuan Ping Hsia, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMJ Open|July 9, 2018
Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countriesHsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, et al.
World Journal of Gastrointestinal Surgery|January 2, 2026
Outcomes of robotic liver resection and intraoperative radiofrequency ablation for hepatocellular carcinoma in posterior segments VII and VIIICheng-Ming Peng, Shao-Chieh Lin, Yung-Yin Cheng, et al.
Cancer Medicine|February 24, 2023
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapyCho-Han Chiang, Yu-Cheng Chang, Shih-Syuan Wang, et al.
Surgical Endoscopy|July 24, 2024
Reduced-port robotic pancreaticoduodenectomy with optimized surgical field deployment: early results of single-site plus-two ports methodRiki Ninomiya, Masahiko Komagome, Satoru Abe, et al.
Oncology|May 28, 2023
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint InhibitorsCho-Han Chiang, Yuan-Jen Chen, Xin Ya See, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2023
Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort studyCho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, et al.
Japanese Journal of Clinical Oncology|October 8, 2022
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populationsCho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, et al.
American Journal of Cancer Research|December 12, 2022
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinomaNai-Jung Chiang, Yan-Shen Shan, Chung-Pin Li, et al.
Journal of Gastroenterology and Hepatology|January 31, 2024
The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancerCho-Han Chiang, Cho-Hung Chiang, Yuan Ping Hsia, et al.
Pageof 5